07:00 , Aug 22, 2016 |  BC Week In Review  |  Financial News

ProteoMediX completes venture financing

ProteoMediX AG , Zurich, Switzerland   Business: Diagnostic   Date completed: 2016-08-16   Type: Venture financing   Raised: CHF5 million ($5.1 million)   Investors: Altos Venture; Zuercher Kantonalbank; existing investors; private investors  ...
07:00 , Apr 14, 2014 |  BC Week In Review  |  Financial News

ProteoMediX completes venture financing

ProteoMediX AG , Zurich, Switzerland   Business: Cancer, Diagnostic   Date completed: 4/9/14   Type: Venture financing   Raised: CHF3.2 million ($3.6 million)   Investors: Altos Venture; Zuercher Kantonalbank; existing investors  ...
07:00 , Jun 4, 2012 |  BioCentury  |  Emerging Company Profile

ProteoMediX: Prostate's PI3K biomarkers

ProteoMedix AG is developing a multiplexed ELISA-based blood test that aims to confirm an initial PSA positive result and reduce unneeded biopsies by monitoring a quartet of biomarkers associated with alterations in PI3K signaling, a...
08:00 , Jan 23, 2012 |  BC Week In Review  |  Financial News

ProteoMediX completes venture financing

ProteoMediX AG , Zurich, Switzerland   Business: Cancer, Diagnostic   Date completed: 1/19/12   Type: Venture financing   Raised: CHF2.6 million ($2.7 million)   Investors: Altos Venture; private investors  ...
01:13 , Jan 20, 2012 |  BC Extra  |  Financial News

ProteoMedix raises $2.7M in series A

Cancer diagnostic company ProteoMedix AG (Zurich, Switzerland) raised CHF2.6 million ($2.7 million) in a series A round led by Altos Venture with participation from private investors. ProteoMedix is developing a blood-based prostate cancer test that...